Iadonato, Shawn P.
Kineta (United States)
3 papers on CoChat
Most cited papers
- Verified
Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: A randomized phase 1b trial
Tarcha, E. J., Olsen, C. M., Probst, P., Peckham, D., Muñoz-Elías, E. J., Kruger, J. G., & Iadonato, S. P. (2017) · PLOS ONE
Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases
Cited by 167
- Verified
Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease
Tarcha, E. J., Chi, V., Muñoz-Elías, E. J., Bailey, D., Londono, L. M., Upadhyay, S. K., Norton, K., Banks, A., Tjong, I., Nguyen, H., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics
Ion channel regulation and functionT-cell and B-cell Immunology
Cited by 117
- Verified
Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases
Chhabra, S., Chang, S. C., Nguyen, H. M., Huq, R., Tanner, M. R., Londono, L. M., Estrada, R., Dhawan, V., Chauhan, S., Upadhyay, S. K., et al. (2014) · The FASEB Journal
Parasites and Host InteractionsIon channel regulation and function
Cited by 91
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free